Analysing mutations with correct and reliable genetic testing in the significant genes (BRCA1 and BRCA2) and less commonly mutated genes (such as PTEN) and subsequent genetic counselling in high‐risk women can be beneficial in the early detection and/or prevention of breast cancer development (Table 1). This evidence concerns the gene BRCA1 and breast cancer.